...
首页> 外文期刊>Journal of Medicinal Chemistry >Discovery, Optimization, and Biological Evaluation of Sulfonamidoacetamides as an Inducer of Axon Regeneration
【24h】

Discovery, Optimization, and Biological Evaluation of Sulfonamidoacetamides as an Inducer of Axon Regeneration

机译:磺酰胺基乙酰胺作为轴突再生的诱导剂的发现,优化和生物学评估。

获取原文
获取原文并翻译 | 示例

摘要

Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential, and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways. Here we report phenotypic cell-based screen of chemical libraries and structure activity-guided optimization that resulted in the identification of compound 7p which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. In an animal model of optic nerve injury, compound 7p was shown to induce growth of GAP-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p translates into stimulation of axon regeneration in vivo. Further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.
机译:中枢神经系统损伤后轴突再生受到一定程度的阻碍,这是因为如果内在性轴突生长潜能的年龄依赖性下降以及刺激受损神经元中轴突生长的策略之一涉及涉及信号通路的药理操作。在这里,我们报告基于表型细胞的化学文库筛选和结构活性指导的优化,最终鉴定出化合物7p,该化合物促进了源自海马,大脑皮层和视网膜的培养初级神经元的神经突向外生长。在视神经损伤的动物模型中,化合物7p显示出能诱导GAP-43阳性轴突生长,表明化合物7p的体外神经突生长活性转化为体内刺激轴突再生。化合物7p的进一步优化及其在体内引起轴突再生的机理的阐明将为将来增强治疗策略的努力提供合理的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号